Q5108 Injection, fulphila
Also known as: Fulphila injection, pegfilgrastim-jmdb, peg-filgrastim
Injection of Fulphila, pegfilgrastim-jmdb biosimilar, a long-acting granulocyte-colony stimulating factor.
In Plain Language
long-acting white blood cell booster; extended chemotherapy support
Clinical Context
Used to prevent chemotherapy-induced neutropenia in cancer patients requiring extended hematopoietic support.
RVU Information
CPT Q5108 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5108?
CPT Q5108 (Injection, fulphila) is a Q Codes code. Injection of Fulphila, pegfilgrastim-jmdb biosimilar, a long-acting granulocyte-colony stimulating factor.
Is Q5108 covered by insurance?
Q5108 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used to prevent chemotherapy-induced neutropenia in cancer patients requiring extended hematopoietic support.
When is CPT Q5108 used?
Used to prevent chemotherapy-induced neutropenia in cancer patients requiring extended hematopoietic support.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.